Core Viewpoint - The company expects a net profit of 263 million to 283 million yuan for the first three quarters of 2025, representing a year-on-year growth of 9.55% to 17.87% [1] Financial Performance - The projected net profit for the third quarter of 2025 is expected to be positive, although the specific amount has not been disclosed [1] - The anticipated operating revenue for the first three quarters of 2025 is between 2.741 billion and 2.901 billion yuan, which indicates a decline of 1.18% to 6.63% compared to the same period last year [1] Growth Drivers - The company attributes its performance growth to proactive revenue enhancement and inspection promotion efforts in the third quarter, along with ongoing cost reduction and efficiency improvement measures [1]
美年健康:预计前三季度净利润同比增长9.55%-17.87%